Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly FCF Margin of 7717.17% for Q3 2025, down 673688.0% year-over-year from N/an in Q3 2024, and up 37.78% quarter-over-quarter from 12403.11% in Q2 2025.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' FCF Margin history runs 4 years deep, the most recent figure standing at 7717.17% for Q3 2025.
- In Q3 2025, FCF Margin fell 673688.0% year-over-year to 7717.17%; the TTM figure through Sep 2025 stood at 3519.33% (down 234456.0% YoY), while the FY2024 annual figure was 1255.57%, up 5267.0% from the prior year.
- FCF Margin for Q3 2025 stood at 7717.17%, up from 12403.11% in the prior quarter.
- The five-year high for FCF Margin was 1399.91% in Q3 2022, with the low at 12403.11% in Q2 2025.
- The 4-year median for FCF Margin is 1713.16% (2024), against an average of 2595.0%.
- The sharpest annual moves came in 2024 and 2025: FCF Margin surged 71296 bps in 2024, then plunged 1162238 bps in 2025.
- Dianthus Therapeutics' FCF Margin stood at 755.74% in 2022, then sank by 269 bps to 2784.98% in 2023, then increased by 26 bps to 2072.02% in 2024, then sank by 272 bps to 7717.17% in 2025.
- Business Quant data shows DNTH's FCF Margin at 7717.17% in Q3 2025, 12403.11% in Q2 2025, and 2304.5% in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -7,717.17% |
| Jun 30, 2025 | -12,403.11% |
| Mar 31, 2025 | -2,377.82% |
| Dec 31, 2024 | -2,072.02% |
| Sep 30, 2024 | -980.29% |
| Jun 30, 2024 | -780.73% |
| Mar 31, 2024 | -1,713.16% |
| Dec 31, 2023 | -2,596.06% |
| Sep 30, 2023 | -1,088.42% |
| Jun 30, 2023 | -475.20% |
| Mar 31, 2023 | -2,059.60% |
| Dec 31, 2022 | -755.74% |
| Sep 30, 2022 | 1,399.91% |